Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Poupak Fallahi, Francesca Ragusa, Sabrina Rosaria Paparo, Giusy Elia, Eugenia Balestri, Valeria Mazzi, Armando Patrizio, Chiara Botrini, Salvatore Benvenga, Silvia Martina Ferrari & Alessandro Antonelli. (2023) Teprotumumab for the treatment of thyroid eye disease. Expert Opinion on Biological Therapy 23:2, pages 123-131.
Read now
Read now
Jing Yi Lai, Stephan Klatt & Theam Soon Lim. (2019) Potential application of Leishmania tarentolae as an alternative platform for antibody expression. Critical Reviews in Biotechnology 39:3, pages 380-394.
Read now
Read now
Mauro Alaibac. (2019) Biological therapy of autoimmune blistering diseases. Expert Opinion on Biological Therapy 19:2, pages 149-156.
Read now
Read now
Wilma Barcellini & Bruno Fattizzo. (2018) Autoimmune hemolytic anemia - progress in emerging treatment options. Expert Opinion on Orphan Drugs 6:4, pages 273-282.
Read now
Read now
Bram Verstockt, Gert Van Assche, Séverine Vermeire & Marc Ferrante. (2017) Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease. Expert Opinion on Biological Therapy 17:1, pages 31-47.
Read now
Read now
Roland E. Kontermann. (2016) Half-life extended biotherapeutics. Expert Opinion on Biological Therapy 16:7, pages 903-915.
Read now
Read now
Ingrid J. G. Burvenich, William Farrugia, Fook T. Lee, Bruno Catimel, Zhanqi Liu, Dahna Makris, Diana Cao, Graeme J. O'Keefe, Martin W. Brechbiel, Dylan King, Violeta Spirkoska, Laura C. Allan, Paul A. Ramsland & Andrew M. Scott. (2016) Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor . mAbs 8:4, pages 775-786.
Read now
Read now
Danica B Stanimirovic, Mahmud Bani-Yaghoub, Martin Perkins & Arsalan S Haqqani. (2015) Blood–brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics. Expert Opinion on Drug Discovery 10:2, pages 141-155.
Read now
Read now
Articles from other publishers (36)
Sara Trzos, Paweł Link-Lenczowski & Ewa Pocheć. (2023) The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapy. Frontiers in Immunology 14.
Crossref
Crossref
Linghui Qian, Xuefen Lin, Xue Gao, Rizwan Ullah Khan, Jia-Yu Liao, Shubo Du, Jingyan Ge, Su Zeng & Shao Q. Yao. (2023) The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics. Chemical Reviews 123:12, pages 7782-7853.
Crossref
Crossref
Ashwini Kumar Mishra, Mukesh Pandey, Hitesh Kumar Dewangan, Neha SL & Pravat Kumar Sahoo. (2022) A Comprehensive Review on Liver Targeting: Emphasis on Nanotechnology-
based Molecular Targets and Receptors Mediated Approaches. Current Drug Targets 23:15, pages 1381-1405.
Crossref
Crossref
Jasminka Krištić, Gordan Lauc & Marija Pezer. (2022) Immunoglobulin G glycans – Biomarkers and molecular effectors of aging. Clinica Chimica Acta 535, pages 30-45.
Crossref
Crossref
Yanis Ramdani, Juliette Lamamy, Hervé Watier & Valérie Gouilleux-Gruart. (2022) Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review. International Journal of Molecular Sciences 23:17, pages 9604.
Crossref
Crossref
Yiming Jin, Megan A. Schladetsch, Xueting Huang, Marcy J. Balunas & Andrew J. Wiemer. (2022) Stepping forward in antibody-drug conjugate development. Pharmacology & Therapeutics 229, pages 107917.
Crossref
Crossref
Xujiao Ren, Ping Qian, Shudan Liu, Huanchun Chen & Xiangmin Li. (2021) Fc-Mediated E2-Dimer Subunit Vaccines of Atypical Porcine Pestivirus Induce Efficient Humoral and Cellular Immune Responses in Piglets. Viruses 13:12, pages 2443.
Crossref
Crossref
Hyung Shik Kim & Dong Yun Lee. (2021) Smart engineering of gold nanoparticles to improve intestinal barrier penetration. Journal of Industrial and Engineering Chemistry 102, pages 122-134.
Crossref
Crossref
Desmond Y. H. Yap, Jojo Hai, Paul C. H. Lee, Xueying Zhou, Michael Lee, Yu Zhang, Meng Wang & Xiaoxiang Chen. (2021) Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers. Clinical and Translational Science 14:5, pages 1769-1779.
Crossref
Crossref
Johann Sellner, Harald H. Sitte & Paulus S. Rommer. (2021) Targeting interleukin-6 to treat neuromyelitis optica spectrum disorders: Implications from immunology, the FcRn pathway and clinical experience. Drug Discovery Today 26:7, pages 1591-1601.
Crossref
Crossref
P. S. Obukhova, A. V. KachanovN. A. PozdnyakovaM. M. Ziganshina. (2021) AB0-incompatibility of mother and fetus: the role of anti-glycan alloantibodies in the hemolytic disease of newborns. Medical Immunology (Russia) 23:1, pages 17-34.
Crossref
Crossref
Shih-Ting Hong, Yu-Cheng Su, Yu-Jen Wang, Tian-Lu Cheng & Yeng-Tseng Wang. (2021) Anti-TNF Alpha Antibody Humira with pH-dependent Binding Characteristics: A constant-pH Molecular Dynamics, Gaussian Accelerated Molecular Dynamics, and In Vitro Study. Biomolecules 11:2, pages 334.
Crossref
Crossref
Clara J. Men, Andrea L. Kossler & Sara T. Wester. (2021) Updates on the understanding and management of thyroid eye disease. Therapeutic Advances in Ophthalmology 13, pages 251584142110277.
Crossref
Crossref
Katia P. Seremeta & Alejandro Sosnik. 2020. Nanotechnology for Oral Drug Delivery. Nanotechnology for Oral Drug Delivery
199
224
.
Jean-Philippe Julien & Hedda Wardemann. (2019) Antibodies against Plasmodium falciparum malaria at the molecular level. Nature Reviews Immunology 19:12, pages 761-775.
Crossref
Crossref
Hyun-Jong Ahn, Cheung-Seog Park & Jeong Je Cho. (2019) Application of therapeutic protein-based fusion toxins. Molecular & Cellular Toxicology 15:4, pages 369-381.
Crossref
Crossref
A. R. Satvik Iyengar, Shreya Gupta, Snehal Jawalekar & Abhay H. Pande. (2019) Protein Chimerization: A New Frontier for Engineering Protein Therapeutics with Improved Pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics 370:3, pages 703-714.
Crossref
Crossref
Maartje G. Huijbers, Jaap J. Plomp, Inge E. van Es, Yvonne E. Fillié-Grijpma, Samar Kamar-Al Majidi, Peter Ulrichts, Hans de Haard, Erik Hofman, Silvère M. van der Maarel & Jan J. Verschuuren. (2019) Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis. Experimental Neurology 317, pages 133-143.
Crossref
Crossref
Kenneth W. Walker, Hossein Salimi-Moosavi, Gregory E. Arnold, Qing Chen, Marcus Soto, Frederick W. Jacobsen & John Hui. (2019) Pharmacokinetic comparison of a diverse panel of non-targeting human antibodies as matched IgG1 and IgG2 isotypes in rodents and non-human primates. PLOS ONE 14:5, pages e0217061.
Crossref
Crossref
Meghdad Abdollahpour‐Alitappeh, Majid Lotfinia, Tohid Gharibi, Jalal Mardaneh, Behrouz Farhadihosseinabadi, Pegah Larki, Babak Faghfourian, Koushan Sineh Sepehr, Kazem Abbaszadeh‐Goudarzi, Ghasem Abbaszadeh‐Goudarzi, Behrooz Johari, Mohammad Reza Zali & Nader Bagheri. (2018) Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology 234:5, pages 5628-5642.
Crossref
Crossref
Eszter Lázár-Molnár & Julio C Delgado. (2019) Implications of Monoclonal Antibody Therapeutics Use for Clinical Laboratory Testing. Clinical Chemistry 65:3, pages 393-405.
Crossref
Crossref
Terezia Kiskova, Yuliya Mytsko, Martin Schepelmann, Hanns Helmer, Renate Fuchs, Heidi Miedl, Christian Wadsack & Isabella Ellinger. (2019) Expression of the neonatal Fc-receptor in placental-fetal endothelium and in cells of the placental immune system. Placenta 78, pages 36-43.
Crossref
Crossref
A. Razzaque Ahmed & Srinivas Kaveri. (2018) Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin. Frontiers in Immunology 9.
Crossref
Crossref
Daniel Stöppler, Alex Macpherson, Susanne Smith-Penzel, Nicolas Basse, Fabien Lecomte, Hervé Deboves, Richard D. Taylor, Tim Norman, John Porter, Lorna C. Waters, Marta Westwood, Ben Cossins, Katharine Cain, James White, Robert Griffin, Christine Prosser, Sebastian Kelm, Amy H. Sullivan, David Fox, Mark D. Carr, Alistair Henry, Richard Taylor, Beat H. Meier, Hartmut Oschkinat & Alastair D. Lawson. (2018) Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMR. PLOS Biology 16:5, pages e2006192.
Crossref
Crossref
Yonghe Ma, Cuncun Ke, Zihui Wan, Zili Li, Xueqian Cheng, Xifeng Wang, Jinshan Zhao, Youji Ma, Liming Ren, Haitang Han & Yaofeng Zhao. (2018) Truncation of the Murine Neonatal Fc Receptor Cytoplasmic Tail Does Not Alter IgG Metabolism or Transport In Vivo. The Journal of Immunology 200:4, pages 1413-1424.
Crossref
Crossref
O. S. Qureshi, T. F. Rowley, F. Junker, S. J. Peters, S. Crilly, J. Compson, A. Eddleston, H. Björkelund, K. Greenslade, M. Parkinson, N. L. Davies, R. Griffin, T. L. Pither, K. Cain, L. Christodoulou, L. Staelens, E. Ward, J. Tibbitts, A. Kiessling, B. Smith, F. R. Brennan, M. Malmqvist, F. Fallah-Arani & D. P. Humphreys. (2017) Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions. Scientific Reports 7:1.
Crossref
Crossref
Lena D’Hooghe, Andrew D. Chalmers, Sam Heywood & Paul Whitley. (2017) Cell surface dynamics and cellular distribution of endogenous FcRn. PLOS ONE 12:8, pages e0182695.
Crossref
Crossref
Lin Wu, Mingyu Chen, Huijuan Mao, Ningning Wang, Bo Zhang, Xiufen Zhao, Jun Qian & Changying Xing. (2017) Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal Fc receptor in glomerular podocytes. International Journal of Molecular Medicine 39:4, pages 851-860.
Crossref
Crossref
Thomas Billiet, Erwin Dreesen, Isabelle Cleynen, Willem-Jan Wollants, Marc Ferrante, Gert Van Assche, Ann Gils & Severine Vermeire. (2016) A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease. American Journal of Gastroenterology 111:10, pages 1438-1445.
Crossref
Crossref
João Pedro Martins, Patrick J. Kennedy, Hélder A. Santos, Cristina Barrias & Bruno Sarmento. (2016) A comprehensive review of the neonatal Fc receptor and its application in drug delivery. Pharmacology & Therapeutics 161, pages 22-39.
Crossref
Crossref
Daria A. Burmistrova, Sergey V. Tillib, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Dmitry N. Shcherbinin, Olga V. Zubkova, Tatiana I. Ivanova, Amir I. Tukhvatulin, Maxim M. Shmarov, Denis Y. Logunov, Boris S. Naroditsky & Aleksandr L. Gintsburg. (2016) Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis. PLOS ONE 11:3, pages e0150958.
Crossref
Crossref
Stian Foss, Algirdas Grevys, Kine Marita Knudsen Sand, Malin Bern, Pat Blundell, Terje E. Michaelsen, Richard J. Pleass, Inger Sandlie & Jan Terje Andersen. (2016) Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization. Journal of Controlled Release 223, pages 42-52.
Crossref
Crossref
Christina PetersStuart Brown. (2015) Antibody–drug conjugates as novel anti-cancer chemotherapeutics. Bioscience Reports 35:4.
Crossref
Crossref
Quinlin M. Hanson & Adam W. Barb. (2015) A Perspective on the Structure and Receptor Binding Properties of Immunoglobulin G Fc. Biochemistry 54:19, pages 2931-2942.
Crossref
Crossref
Abdulgabar Salama. (2015) Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review. Transfusion Medicine and Hemotherapy 42:5, pages 294-301.
Crossref
Crossref
Tianlei Ying, Rui Gong, Tina W. Ju, Ponraj Prabakaran & Dimiter S. Dimitrov. (2014) Engineered Fc based antibody domains and fragments as novel scaffolds. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1844:11, pages 1977-1982.
Crossref
Crossref